exRNAdisease

Entry Detail

---



General Information

Database ID: exR0202795 RNA Name: hsa-miR-520d-3p RNA Type: miRNA Chromosome: chr19 Starnd: + Coordinate: Start Site(bp): 53720149 End Site(bp): 53720170 External Links: hsa-miR-520d-3p

Disease Information

Disease Name: Mild Cognitive Impairment Disease Category: Other Diseases MeSH ID: D060825 Type: Psychiatry and Psychology Category/Mental Disorders Alias: Cognitive Dysfunction//Cognitive Dysfunctions//Dysfunction, Cognitive//Dysfunctions, Cognitive//Cognitive Impairments//Cognitive Impairment//Impairment, Cognitive//Impairments, Cognitive//Mild Cognitive Impairment//Cognitive Impairment, Mild//Cognitive Impairments, Mild//Impairment, Mild Cognitive//Impairments, Mild Cognitive//Mild Cognitive Impairments//Mild Neurocognitive Disorder//Disorder, Mild Neurocognitive//Disorders, Mild Neurocognitive//Mild Neurocognitive Disorders//Neurocognitive Disorder, Mild//Neurocognitive Disorders, Mild//Cognitive Decline//Cognitive Declines//Decline, Cognitive//Declines, Cognitive//Mental Deterioration//Deterioration, Mental//Deteriorations, Mental//Mental Deteriorations

Expression Detail

GEO ID: GSE120584 Description: Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression data Experimental Design: Disease vs Control Case Disease Type: Alzheimer's Disease Case Disease SubType: NA Case Sample: Mild Cognitive Impairment Control Sample: Normal Number of Case: 1021 Number of Control: 288 Number of Samples: 1309

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand CAMK2N1 chr1 20482391 20486210 - KIAA1522 chr1 32741830 32774970 + RGMA chr15 93035273 93089204 - APP chr21 25880550 26171128 - ATP6V1B2 chr8 20197381 20226819 + CUL1 chr7 148697914 148801110 + WASF3 chr13 26557683 26688948 + ATP6V1C1 chr8 103021063 103073051 + FYCO1 chr3 45917899 45995824 - DIP2A chr21 46458891 46570015 + LONP2 chr16 48244300 48363122 + ARL4A chr7 12686856 12690958 + ZSCAN26 chr6 28267010 28278224 + PLAGL2 chr20 32192504 32207743 - MLLT1 chr19 6210381 6279975 - SRRT chr7 100875103 100888664 + AMPD2 chr1 109616104 109632053 + GLCE chr15 69160584 69272217 + ZFAND4 chr10 45615500 45672780 - MTF1 chr1 37809574 37859592 - FAM102A chr9 127940582 127980989 - CCDC93 chr2 117915478 118014133 - VLDLR chr9 2621787 2660056 + ATXN1 chr6 16299112 16761491 - PHC3 chr3 170086732 170181749 - CELF2 chr10 10798397 11336675 + SCAMP2 chr15 74843730 74873365 - SEMA3C chr7 80742538 80922359 - CHD9 chr16 53055033 53329150 + MNT chr17 2384073 2401104 - miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0000943 chr19 47421744 47440665 + lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AL049840.4 chr14 103694516 103695050 - ARHGAP27P1-BPTFP1-KPNA2P3 chr17 64749663 64781707 - FGD5-AS1 chr3 14920347 14948424 - MIR17HG chr13 91347820 91354579 + NEAT1 chr11 65422774 65445540 + NORAD chr20 36045618 36051018 - SNHG16 chr17 76557764 76565348 + XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE120584 Sample Source: Blood Source Fraction: Serum Platform: GPL21263 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 2532 Sample treatment protocol: NA RNA Extract protocol: Total RNA was extracted each from 300uL serum samples using 3D-Gene® RNA extraction reagent from liquid sample kit (Toray Industries, Inc.). RNA library preparation protocol: miRNA was labeled using 3D-Gene® miRNA Labeling kit in accordance with the manufacturer's instructions.

Reference

PMID: 30820472 Title: Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression data Author: Shigemizu D, Akiyama S, Asanomi Y, Boroevich KA, Sharma A, Tsunoda T, Matsukuma K, Ichikawa M, Sudo H, Takizawa S, Sakurai T, Ozaki K, Ochiya T, Niida S Journal: Commun Biol. 2019 Feb 25;2:77. Description: we investigated potential miRNA biomarkers and constructed risk prediction models, based on a supervised principal component analysis (PCA) logistic regression method, according to the subtype of dementia